Cancer evolution: Darwin and beyond

R Vendramin, K Litchfield, C Swanton - The EMBO journal, 2021 - embopress.org
Clinical and laboratory studies over recent decades have established branched evolution as
a feature of cancer. However, while grounded in somatic selection, several lines of evidence …

Properties and application of cell-free DNA as a clinical biomarker

FS de Miranda, VG Barauna, L Dos Santos… - International Journal of …, 2021 - mdpi.com
Biomarkers are valuable tools in clinical practice. In 2001, the National Institutes of Health
(NIH) standardized the definition of a biomarker as a characteristic that is objectively …

The provocative roles of platelets in liver disease and cancer

P Kanikarla Marie, NW Fowlkes… - Frontiers in …, 2021 - frontiersin.org
Both platelets and the liver play important roles in the processes of coagulation and innate
immunity. Platelet responses at the site of an injury are rapid; their immediate activation and …

[HTML][HTML] The provocative roles of platelets in liver disease and cancer

PK Marie, NW Fowlkes, V Afshar-Kharghan… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
Both platelets and the liver play important roles in the processes of coagulation and innate
immunity. Platelet responses at the site of an injury are rapid; their immediate activation and …

Liquid biopsy in ovarian cancer

BK Bhardwaj, S Thankachan, T Venkatesh… - Clinica Chimica Acta, 2020 - Elsevier
Ovarian cancer is typically diagnosed at an advanced stage and poses a significant
challenge to treatment and recovery. Relapsed ovarian cancer and chemoresistance of …

Future directions in the use of SAbR for the treatment of oligometastatic cancers

Z Morris, M Dohopolski, A Rahimi… - Seminars in Radiation …, 2021 - Elsevier
The role of local therapy as a sole therapy or part of a combined approach in treating
metastatic cancer continues to evolve. The most obvious requirements for prudent …

[HTML][HTML] Circulating tumor DNA in clinical trials for solid tumors: Challenges and current applications

C Parisi, M Tagliamento, L Belcaid, M Aldea… - The Journal of Liquid …, 2023 - Elsevier
Tumor derived biomarkers including circulating tumor DNA (ctDNA) and/or circulating
tumors cells (CTCs) may be detected and quantified through liquid biopsy (LB). ctDNA …

Circulating tumor DNA (ctDNA) application in investigation of cancer: bench to bedside

HO Alsaab, MS Alzahrani, AA Bahauddin… - Archives of Biochemistry …, 2024 - Elsevier
Now, genomics forms the core of the precision medicine concept. Comprehensive
investigations of tumor genomes have made it possible to characterize tumors at the …

Ready-to-use nanopore platform for the detection of any DNA/RNA oligo at attomole range using an Osmium tagged complementary probe

ASW Kang, JG Bernasconi, W Jack, A Kanavarioti - Scientific reports, 2020 - nature.com
Nanopores can serve as single molecule sensors. We exploited the MinION, a portable
nanopore device from Oxford Nanopore Technologies, and repurposed it to detect any …

An overview: genetic tumor markers for early detection and current gene therapy strategies

R Quraish, T Hirahata, A Quraish… - Cancer …, 2023 - journals.sagepub.com
Genomic instability is considered a fundamental factor involved in any neoplastic disease.
Consequently, the genetically unstable cells contribute to intratumoral genetic heterogeneity …